Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹31,410 Cr
Revenue (TTM)
₹4,193 Cr
Net Profit (TTM)
₹754 Cr
ROE
21.8 %
ROCE
26.7 %
P/E Ratio
41.7
P/B Ratio
7.8
Industry P/E
26.59
EV/EBITDA
26.2
Div. Yield
0.8 %
Debt to Equity
0
Book Value
₹249.4
EPS
₹48.2
Face value
1
Shares outstanding
160,558,706
CFO
₹3,748.12 Cr
EBITDA
₹5,035.48 Cr
Net Profit
₹3,408.91 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
JB Chemicals
| 7.8 | -4.5 | 7.8 | 26.5 | 25.7 | 25.7 | 31.7 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
JB Chemicals
| -3.1 | 14.1 | 67.1 | 9.3 | 72.1 | 136.8 | 36.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
JB Chemicals
|
1,961.1 | 31,410.1 | 4,193.0 | 753.8 | 22.7 | 20.8 | 41.7 | 7.8 |
| 2,791.2 | 34,920.1 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.4 | 7.6 | |
| 7,827.5 | 19,544.3 | 2,177.5 | 200.9 | 11.3 | 26.5 | 97.3 | 23.5 | |
| 1,565.8 | 11,917.5 | 2,089.5 | 622.0 | 31.3 | 20.4 | 19.4 | 3.6 | |
| 1,332.1 | 18,429.0 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.7 | 5.1 | |
| 4,887.1 | 22,333.8 | 2,482.3 | 853.6 | 33.7 | 18.9 | 26.2 | 5.6 | |
| 4,778.6 | 7,918.9 | 1,348.5 | 293.5 | 28.1 | 50.7 | 27 | 11.4 | |
| 3,265.0 | 7,519.5 | 1,837.4 | 326.7 | 24.7 | 44.5 | 23 | 11.1 | |
| 388.9 | 7,603.2 | 1,432.0 | 149.0 | 19.1 | 7.9 | 50.7 | 3.1 | |
| 971.2 | 8,938.5 | 4,725.6 | 528.7 | 14.9 | 20.7 | 17.5 | 3.0 |
No Review & Analysis are available.
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium,... diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, the company offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. It provides its products to gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India. Read more
Incorporated
1976
Chairman
Arun Duggal
Managing Director
Aman Mehta
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about JB Chemicals & Pharmaceuticals Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of JB Chemicals & Pharmaceuticals Ltd is ₹1,961.10 (NSE) and ₹1,956.30 (BSE) as of 02-Apr-2026 IST. JB Chemicals & Pharmaceuticals Ltd has given a return of 25.67% in the last 3 years.
The P/E ratio of JB Chemicals & Pharmaceuticals Ltd is 41.67 times as on 02-Apr-2026, a 57 premium to its peers’ median range of 26.59 times.
The P/B ratio of JB Chemicals & Pharmaceuticals Ltd is 7.84 times as on 02-Apr-2026, a 75 premium to its peers’ median range of 4.49 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
38.29
|
7.73
|
|
2024
|
46.32
|
9.20
|
|
2023
|
18.61
|
6.47
|
|
2022
|
31.59
|
5.88
|
|
2021
|
21.63
|
5.35
|
The 52-week high and low of JB Chemicals & Pharmaceuticals Ltd are Rs 2,195.00 and Rs 1,385.75 as of 03-Apr-2026.
JB Chemicals & Pharmaceuticals Ltd has a market capitalisation of ₹ 31,410 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in JB Chemicals & Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-47.70
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.